(NPO) Enpro Industries - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 6.398m USD | Total Return: 70.1% in 12m
Avg Turnover: 77.2M
EPS Trend: 8.1%
Qual. Beats: 0
Rev. Trend: 52.8%
Qual. Beats: 0
Warnings
P/E ratio 147.0
Below Avwap Earnings
Tailwinds
No distinct edge detected
Enpro Inc. (NPO) is a diversified industrial technology firm specializing in engineered components and services for critical environments. The company operates through two primary segments: Sealing Technologies and Advanced Surface Technologies. Its portfolio includes high-performance gaskets, seals, and precision sub-systems utilized in semiconductor fabrication, aerospace, and biopharmaceutical processing.
The business model focuses on proprietary, high-margin products that are essential to customer operations but represent a small fraction of total system costs. This creates high switching costs and recurring revenue through the replacement of consumable parts. In the semiconductor sector, Enpro provides specialized cleaning and coating services for wafer processing equipment, a market driven by the increasing complexity of node transitions.
A closer look at ValueRay can help you determine how these industrial tailwinds impact the companys intrinsic valuation.
Headquartered in Charlotte, North Carolina, the company rebranded from EnPro Industries to Enpro Inc. in late 2023. It maintains a global manufacturing and distribution footprint across North America, Europe, and Asia to serve its international client base.
- Semiconductor capital equipment spending cycles dictate Advanced Surface Technologies segment revenue
- Expansion into biopharmaceutical and food markets diversifies Sealing Technologies earnings
- Shift toward high-margin proprietary products improves consolidated EBITDA margins
- Aerospace and defense sector demand stabilizes long-term order backlogs
- Fluctuations in raw material costs and global supply chains impact production overhead
| Net Income: 43.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.82 > 1.0 |
| NWC/Revenue: 20.18% < 20% (prev 33.81%; Δ -13.64% < -1%) |
| CFO/TA 0.08 > 3% & CFO 219.8m > Net Income 43.4m |
| Net Debt (538.6m) to EBITDA (200.9m): 2.68 < 3 |
| Current Ratio: 2.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.1m) vs 12m ago -0.47% < -2% |
| Gross Margin: 42.56% > 18% (prev 0.43%; Δ 4.21k% > 0.5%) |
| Asset Turnover: 45.63% > 50% (prev 42.46%; Δ 3.16% > 0%) |
| Interest Coverage Ratio: 2.80 > 6 (EBITDA TTM 200.9m / Interest Expense TTM 34.2m) |
| A: 0.09 (Total Current Assets 433.2m - Total Current Liabilities 196.5m) / Total Assets 2.64b |
| B: 0.46 (Retained Earnings 1.21b / Total Assets 2.64b) |
| C: 0.04 (EBIT TTM 95.8m / Avg Total Assets 2.57b) |
| D: 1.15 (Book Value of Equity 1.23b / Total Liabilities 1.07b) |
| Altman-Z'' = 3.55 = A |
| DSRI: 1.03 (Receivables 163.8m/144.2m, Revenue 1.17b/1.06b) |
| GMI: 1.01 (GM 42.56% / 42.92%) |
| AQI: 1.06 (AQ_t 0.75 / AQ_t-1 0.71) |
| SGI: 1.10 (Revenue 1.17b / 1.06b) |
| TATA: -0.07 (NI 43.4m - CFO 219.8m) / TA 2.64b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 302.86 with a total of 166,241 shares traded.
Over the past week, the price has changed by -1.12%,
over one month by +4.67%,
over three months by +11.02% and
over the past year by +70.05%.
Enpro Industries has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy NPO.
- StrongBuy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 327 | 8% |
P/E Forward = 33.7838
P/S = 5.4543
P/B = 4.1295
P/EG = 2.2538
Revenue TTM = 1.17b USD
EBIT TTM = 95.8m USD
EBITDA TTM = 200.9m USD
Long Term Debt = 605.2m USD (from longTermDebt, last quarter)
Short Term Debt = 200k USD (from shortTermDebt, last quarter)
Debt = 617.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 12.4m
Net Debt = 538.6m USD (calculated: Debt 617.8m - CCE 79.2m)
Enterprise Value = 6.94b USD (6.40b + Debt 617.8m - CCE 79.2m)
Interest Coverage Ratio = 2.80 (Ebit TTM 95.8m / Interest Expense TTM 34.2m)
EV/FCF = 40.17x (Enterprise Value 6.94b / FCF TTM 172.7m)
FCF Yield = 2.49% (FCF TTM 172.7m / Enterprise Value 6.94b)
FCF Margin = 14.72% (FCF TTM 172.7m / Revenue TTM 1.17b)
Net Margin = 3.70% (Net Income TTM 43.4m / Revenue TTM 1.17b)
Gross Margin = 42.56% ((Revenue TTM 1.17b - Cost of Revenue TTM 673.8m) / Revenue TTM)
Gross Margin QoQ = 42.90% (prev 42.08%)
Tobins Q-Ratio = 2.63 (Enterprise Value 6.94b / Total Assets 2.64b)
Interest Expense / Debt = 5.54% (Interest Expense 34.2m / Debt 617.8m)
Taxrate = 19.17% (6.50m / 33.9m)
NOPAT = 77.4m (EBIT 95.8m * (1 - 19.17%))
Current Ratio = 2.20 (Total Current Assets 433.2m / Total Current Liabilities 196.5m)
Debt / Equity = 0.40 (Debt 617.8m / totalStockholderEquity, last quarter 1.56b)
Debt / EBITDA = 2.68 (Net Debt 538.6m / EBITDA 200.9m)
Debt / FCF = 3.12 (Net Debt 538.6m / FCF TTM 172.7m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.69% (Net Income 43.4m / Total Assets 2.64b)
RoE = 2.83% (Net Income TTM 43.4m / Total Stockholder Equity 1.53b)
RoCE = 4.48% (EBIT 95.8m / Capital Employed (Equity 1.53b + L.T.Debt 605.2m))
RoIC = 3.19% (NOPAT 77.4m / Invested Capital 2.42b)
WACC = 10.70% (E(6.40b)/V(7.02b) * Re(11.30%) + D(617.8m)/V(7.02b) * Rd(5.54%) * (1-Tc(0.19)))
Discount Rate = 11.30% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 42.16 | Cagr: 0.21%
[DCF] Terminal Value 70.76% ; FCFF base≈161.1m ; Y1≈184.6m ; Y5≈271.7m
[DCF] Fair Price = 111.2 (EV 2.89b - Net Debt 538.6m = Equity 2.35b / Shares 21.1m; r=10.70% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 8.14 | EPS CAGR: 0.75% | SUE: 0.08 | # QB: 0
Revenue Correlation: 52.77 | Revenue CAGR: 2.44% | SUE: -0.11 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.32 | Chg30d=+0.28% | Revisions=-14% | Analysts=3
EPS next Quarter (2026-09-30): EPS=2.31 | Chg30d=+2.81% | Revisions=+14% | Analysts=3
EPS current Year (2026-12-31): EPS=9.21 | Chg30d=+3.25% | Revisions=+43% | GrowthEPS=+16.4% | GrowthRev=+12.2%
EPS next Year (2027-12-31): EPS=10.36 | Chg30d=+2.78% | Revisions=+43% | GrowthEPS=+12.5% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: +43%